Proteostasis Therapeutics Inc (PTI)


Stock Price Forecast

Dec. 22, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Proteostasis Therapeutics Inc chart...

About the Company

We do not have any company description for Proteostasis Therapeutics Inc at the moment.

Please visit http://www.proteostasis.com/ for more information about the company.

CEO

Meenu Chhabra

Exchange

NASDAQ/NMS (GLOBAL MARKET)

Website

http://www.proteostasis.com/

$5M

Total Revenue

44

Employees

$67M

Market Capitalization

-1.48

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PTI News

Harold R Werner's Net Worth

1mon ago, source: Benzinga.com

Who is Harold R Werner? Harold R Werner has an estimated net worth of $90.4 Million. This is based on reported shares across multiple companies, which include DIACRIN INC /DE/, TETRALOGIC ...

EFTR eFFECTOR Therapeutics, Inc.

22h ago, source: Seeking Alpha

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product ...

Bihua Chen's Net Worth

1mon ago, source: Benzinga.com

Bihua Chen has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include Corbus Pharmaceuticals Holdings, Inc., MoonLake Immunotherapeutics ...

Intellia Therapeutics Inc NTLA

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ONTX Onconova Therapeutics, Inc.

3d ago, source: Seeking Alpha

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. It has two clinical-stage ...

Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results

21d ago, source: Yahoo Finance

Warning! GuruFocus has detected 2 Warning Sign with DNLI. Denali Therapeutics Inc (NASDAQ:DNLI) released its 8-K filing on February 27, 2024, detailing its financial results for the fourth quarter ...

Pliant Therapeutics, Inc.

1mon ago, source: CNN

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a ...

Viking Therapeutics Inc.

19d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript

18d ago, source: Hosted on MSN

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript February 28, 2024 Voyager Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.25, expectations were $-0.59.

Intellia Therapeutics, Inc.

5mon ago, source: CNN

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...